Recent Studies Highlight Effects of Vitamin D on Diabetes, Alzheimer’s, and Inflammatory Bowel Disease

A study published in April 2026 in JAMA Network Open examined the genetic factors that influence the relationship between vitamin D supplementation and the risk of developing type 2 diabetes. The research indicated that individuals with certain genetic variants (specifically AC or CC variants of the vitamin D receptor gene) experienced a 19% reduction in the risk of prediabetes progressing to type 2 diabetes when taking 4,000 IU of vitamin D daily. However, researchers emphasized the importance of moderation, as excessive vitamin D can lead to negative health effects, and noted that further validation is needed through larger trials. Experts also pointed out that diabetes incidence is influenced by a multitude of factors, making a single supplement unlikely to be a comprehensive preventive measure.

The study contributes to a broader trend toward precision medicine, suggesting that genetic testing could identify individuals most likely to benefit from vitamin D supplementation, especially given the rising rates of type 2 diabetes. Jennifer Cheng, DO, chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center, expressed cautious optimism regarding the findings.

In another study published in April 2026 in Neurology Open Access, researchers from the University of Galway found that higher vitamin D levels in early middle age were associated with lower levels of tau protein—a biomarker for Alzheimer’s disease—measured on brain scans an average of 16 years later. The research did not find a similar correlation with beta-amyloid levels. This study underscores the significance of modifiable risk factors in managing Alzheimer’s, emphasizing that addressing vitamin D deficiency could play a role in reducing the future risk of dementia. However, the sample size was small, and various factors, including lifestyle choices, could have influenced the results, as noted by consultant neurologist Steve Allder, MD.

Lastly, a study published in Cell Reports Medicine investigated the effects of vitamin D on the immune system in individuals with IBD. Over 12 weeks, researchers studied 48 adults with Crohn’s disease or ulcerative colitis and found that vitamin D supplementation helped reduce gut inflammation by promoting a balanced immune response. The results indicated that vitamin D increased levels of the antibody IgA and decreased IgG levels, aiding the body in recognizing beneficial gut bacteria while preventing unnecessary immune attacks. John Mark Gubatan, MD, the study's lead author, highlighted the potential for vitamin D to change treatment approaches for IBD by fostering immune tolerance rather than suppression, calling for more research to refine supplementation strategies for chronic inflammatory conditions.